novavax
-
Trends
Novavax Loses $294 Million In Q1, 25% Of Staff Will Be Laid Off
Novavax Loses $294 Million In Q1, 25% Of Staff Will Be Laid Off In addition, the company announced $800 million…
Read More » -
Trends
Japan approves Novavax COVID-19 vaccine
Japan’s health ministry on Tuesday formally approved Novavax’s COVID-19 vaccine, a fourth foreign-developed tool to combat the infections as the…
Read More » -
Trends
COVID-19 Vaccine Latest Update: By 2024, There will not be Enough Vaccines Available to Everyone!
According to sources, on Monday Adar Poonawalla, CEO of the Serum Institute of India, warned that there would not be enough…
Read More » -
Trends
America’s Novavax strives COVID-19 vaccine deal from India’s Serum Institute!
A COVID-19 vaccine was developed by an American biotech company Novavax and now SII i.e. Serum Institute of India is…
Read More »